Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.41
-0.08 (-0.94%)
Nov 4, 2024, 4:00 PM EST - Market closed

Amneal Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
2,5982,3942,2122,0941,9931,626
Upgrade
Revenue Growth (YoY)
12.37%8.20%5.67%5.08%22.51%-2.20%
Upgrade
Cost of Revenue
1,6331,5301,4211,3101,3401,161
Upgrade
Gross Profit
965.11863.87791.46783.95652.32464.92
Upgrade
Selling, General & Admin
451.07429.68399.7365.5326.73289.6
Upgrade
Research & Development
162.81163.95195.69201.85179.93188.05
Upgrade
Other Operating Expenses
0.07-1.14-3.96---
Upgrade
Operating Expenses
613.95592.49591.43567.35506.66477.65
Upgrade
Operating Income
351.16271.38200.03216.6145.66-12.73
Upgrade
Interest Expense
-241.88-210.63-158.38-136.33-146-168.21
Upgrade
Currency Exchange Gain (Loss)
-2.111.67-12.36-0.3616.35-4.96
Upgrade
Other Non Operating Income (Expenses)
-9.195.1217.8315.332.59194.35
Upgrade
EBT Excluding Unusual Items
97.9767.5447.1395.2518.68.46
Upgrade
Merger & Restructuring Charges
-2.85-1.75-2.13-9.91-11.39-39.97
Upgrade
Gain (Loss) on Sale of Assets
3.8---0.127.26
Upgrade
Asset Writedown
-36.13-36.13-11.11-22.69-34.58-126.16
Upgrade
Legal Settlements
-95.3-1.82-269.93-25-5.86-12.44
Upgrade
Other Unusual Items
-52.32-37.31-1.02-10.57--10.77
Upgrade
Pretax Income
-115.62-40.27-248.1331.37-35.78-220.24
Upgrade
Income Tax Expense
17.588.456.6611.2-104.36383.33
Upgrade
Earnings From Continuing Operations
-133.2-48.72-254.7920.1768.58-603.57
Upgrade
Minority Interest in Earnings
-41.41-35.27124.8-9.5522.48241.66
Upgrade
Net Income
-174.62-83.99-129.9910.6291.06-361.92
Upgrade
Net Income to Common
-174.62-83.99-129.9910.6291.06-361.92
Upgrade
Net Income Growth
----88.33%--
Upgrade
Shares Outstanding (Basic)
254176151149147132
Upgrade
Shares Outstanding (Diluted)
254176151152149132
Upgrade
Shares Change (YoY)
66.75%16.69%-0.58%1.95%12.72%3.81%
Upgrade
EPS (Basic)
-0.69-0.48-0.860.070.62-2.74
Upgrade
EPS (Diluted)
-0.69-0.48-0.860.070.61-2.74
Upgrade
EPS Growth
----88.52%--
Upgrade
Free Cash Flow
207.43298.7816.3190.88317.17-45.48
Upgrade
Free Cash Flow Per Share
0.821.700.111.262.13-0.34
Upgrade
Gross Margin
37.15%36.09%35.78%37.44%32.74%28.59%
Upgrade
Operating Margin
13.52%11.34%9.04%10.35%7.31%-0.78%
Upgrade
Profit Margin
-6.72%-3.51%-5.88%0.51%4.57%-22.25%
Upgrade
Free Cash Flow Margin
7.98%12.48%0.74%9.12%15.92%-2.80%
Upgrade
EBITDA
576.39500.78440.21450381.05230.9
Upgrade
EBITDA Margin
22.19%20.92%19.90%21.49%19.12%14.20%
Upgrade
D&A For EBITDA
225.24229.4240.18233.41235.39243.63
Upgrade
EBIT
351.16271.38200.03216.6145.66-12.73
Upgrade
EBIT Margin
13.52%11.34%9.04%10.35%7.31%-0.78%
Upgrade
Effective Tax Rate
---35.69%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.